Skip to search.
 TSX Up 0.21% TSX Ventures Up 1.43%

Biogen Inc. (BIIB)

-NasdaqGS
289.93 Up 0.90(0.31%) Jul 29, 4:00PM EDT
|After Hours : 290.00 Up 0.07 (0.02%) Jul 29, 7:44PM EDT
Prev Close:289.03
Open:288.85
Bid:276.43 x 100
Ask:290.54 x 100
1y Target Est:332.50
Beta:0.282631
Earnings Date:Oct 19 - Oct 24 (Est.)
Day's Range:286.80 - 290.46
52wk Range:223.02 - 338.51
Volume:1,338,487
Avg Vol (3m):1,880,710
Market Cap:63.53B
P/E (ttm):16.94
EPS (ttm):17.12
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
BIIBUp 0.31%63.53B
PFEUp 0.60%223.73B
ABTUp 0.67%65.74B

Key Statistics

Forward P/E (1 yr):13.85
P/S (ttm):5.64
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :20.14
Quarterly EPS Est (Sep-16) :5.06
Mean Recommendation*:2.1
PEG Ratio (5 yr expected):1.60

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Biogen Inc. discovers, develops, manufactures, and delivers therapies for the treatment of neurodegenerative diseases, hematologic conditions, and autoimmune disorders. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback